georgejjl
13 minutes ago
If blarcamesine is sold at an affordable price, then it can be a true WIN WIN WIN situation, if sold at an affordable price, then people with Alzheimer’s and their caregivers WIN, the government paying the cost on Medicare,etc WIN, and Anavex Life Sciences can WIN with profits in the $BILLION$ year